Skip to main content

Table 1 Demographic features, clinical characteristics, and risk factor information of the study subjects

From: Distinct methylome profile of cfDNA in AMI patients reveals significant alteration in cAMP signaling pathway genes regulating cardiac muscle contraction

Parameters

Subjects (n = 25)

Gender

Males

22 (88%)

Females

3 (12%)

Age

52.12 ± 11.98

 Males

51.13 ± 12.46

 Females

59.33 ± 1.15

 Young AMI (≤ 55)

11 (44%)

 Old AMI (> 55)

14 (56%)

Socio-economic status

Good

13 (52%)

Moderate

3 (12%)

Poor

9 (36%)

Clinical symptoms

Dyspnea

23 (92%)

Palpitation

16 (64%)

Syncope

8 (32%)

Vomiting

13 (52%)

Risk factors

Obesity

12 (48%)

Tobacco

3 (12%)

Alcohol

4 (16%)

Family history

6 (24%)

Diet (non-vegetarian)

10 (40%)

Comorbidity

No comorbidity

9 (36%)

Diabetes

13 (52%)

Hypertension

11 (44%)

Diabetes and hypertension

8 (32%)

Biochemical assays

hs-cTnT (< 0.001 ng/mL)

11.74 ± 12.81

CK-MB (5–25 U/L)

307.28 ± 358.70

CK (22–198 IU/L)

2995.08 ± 2751.41

hs-CRP (1–3 mg/dL)

21.62 ± 25.76

BNP (0–124 pg/mL)

3317.14 ± 3400.11

Molecular assays

cfDNA (ng/uL)

5.08 ± 3.52

gDNA (ng/uL)

460.63 ± 327.01